Company: NIVFW
Filing Date: 2025-10-31
Form Type: 424B3
Source: 0001213900-25-104469
Chunk: 33

Company: NewGenIvf Group Ltd
Filing Date: 2025-10-31
Form: 424B3
Chunk 33
---
 pursuant to Nasdaq Listing Rules 5450(b)(2)(C) (the “MVPHS
Requirement,” and the Company’s non-compliance with this requirement, the “MVPHS Deficiency”). In accordance
with Nasdaq Rule 5810(c)(3)(D), the Company has until the Compliance Date to regain compliance with the MVPHS Requirement. If, at any
time before the Compliance Date, the MVPHS for the Class A Shares is at least $15,000,000 for a minimum of ten consecutive business days,
the Staff will provide the Company written confirmation of compliance with the MVPHS Requirement. In the event the Company does not regain
compliance with the above requirement prior to the expiration of the compliance period, it will receive written notification that its
securities are subject to delisting. Alternatively, the Company may apply to transfer the Company’s securities to The Nasdaq Capital
Market.

On November 21, 2024, the
Company received a notice from the Staff of Nasdaq notifying the Company that its securities are subject to delisting due to the MVPHS
Deficiency and MLVS Deficiency. The Company requested a hearing to appeal the delisting determination before the Nasdaq Hearings Panel
(the “Panel”) on November 27, 2024. On November 29, 2024, the Company received a formal notice from Nasdaq that the Panel
will consider its appeal at an oral hearing on January 28, 2025 (the “Hearing”). On February 19, 2025, the Company
received written decision from the Panel, which granted an extension, allowing the Company additional time to regain compliance with
the Nasdaq Stock Market’s (“Nasdaq” or the “Exchange”) continued listing requirements, subject to meeting
specific compliance criteria within designated timeframes. On February 11, 2025, the Company carried out a 1-for-20 reverse stock split
of its issued and unissued shares. The effect of the reverse stock split was to consolidate every 20 issued and unissued share into one
share. On February 27, 2025, the Company received a notification letter from Nasdaq, indicating that the closing bid price of the Company’s
securities had been at $1.00 per share or greater for 10 consecutive business days from February 11, 2025 to February 26, 2025, and the
Company had regained compliance with the minimum bid price